Royal London Asset Management LTD Exact Sciences Corp Transaction History
Royal London Asset Management LTD
- $40.9 Billion
- Q1 2025
A detailed history of Royal London Asset Management LTD transactions in Exact Sciences Corp stock. As of the latest transaction made, Royal London Asset Management LTD holds 8,343 shares of EXAS stock, worth $471,880. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,343Holding current value
$471,880% of portfolio
0.0%Shares
23 transactions
Others Institutions Holding EXAS
# of Institutions
643Shares Held
157MCall Options Held
1.74MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA17.8MShares$1.01 Billion0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$998 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$707 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$682 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$374 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $10B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...